RBC Capital Initiates Coverage of Legend Biotech (LEGN) with Outperform Recommendation
On March 24, 2023,
RBC Capital
initiated coverage of Legend Biotech with
a Outperform recommendation.
RBC Capital
initiated coverage of Legend Biotech with
a Outperform recommendation.